“A device to detect wheezing for young children...”
Let me helpfully remind you what the product actually does:
+++
The company’s flagship brand, ‘wheezo’, includes a device and app that work together to:
(a) record and analyse breathing for the presence of wheeze; (b) record environmental factors such as pollen counts and air irritants; (c) log self-reported medication use and allows users to set reminders; (d) digitise a person's Asthma Action Plan and allows sharing; (e) upload all of the data to a personalised account in a cloud server; and (f) share data with healthcare professionals.
[Source: Bidder’s Statement, released 29/04, p8]
+++
BUT... if you wish to pretend it’s just a thing that tells people something they already know (and the FDA were wrong to give it the tick of approval, and Cipla were wrong to back the product, and thousands of pharmacies have signed up to stock a dud, and... etc), that’s cool, good luck with your life and your investment decisions! haha
RSH Price at posting:
12.5¢ Sentiment: Buy Disclosure: Held
